On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Cary Gibson, founder of Gibson Health Policy and longtime Washington policy expert, to unpack the latest developments shaping the pharmaceutical landscape. From the Trump administration's push to lower drug prices and the revival of "most favored nation" pricing concepts, to state-level prescription drug boards and 340B reform debates, Cary offers sharp insights on where the pressure points are and what's next for the industry.